ArticlePoultry science2026
Integrated plasma and duodenal content metabolomics reveals metabolic mechanisms underlying residual feed intake differences in broilers.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Characterizing the cross-tissue metabolome of broilers with divergent residual feed intake (RFI) is essential to elucidate the biological basis of feed efficiency (FE). However, single-tissue studies offer limited insight into systemic metabolic crosstalk. Here, untargeted LC-MS/MS metabolomics was employed to analyze the plasma and duodenal content of high- and low-RFI broilers (n = 8/group). We identified 60 differential metabolites (P < 0.05, variable importance in projection (VIP) > 1) in plasma, which were significantly enriched in phenylalanine, tyrosine, and tryptophan biosynthesis, sphingolipid metabolism, glycerophospholipid metabolism, and glutathione metabolism pathways. In the duodenal content, 28 differential metabolites were screened, predominantly mapping to galactose metabolism as well as neurohumoral regulation and cellular network signal transduction pathways. Cross-tissue analysis revealed that Sorbitol was synchronously upregulated in both tissues, while 2-Hydroxyglutarate (2-HG) and N-α-acetyllysine were concurrently downregulated. Conversely, Dihydromyricetin (DMY) and Sphingosine-1-phosphate (S1P) were significantly upregulated in the duodenum but markedly downregulated in the plasma. Notably, S1P in sphingolipid metabolism emerged as a key metabolite bridging local duodenal immune/signaling status with systemic metabolic homeostasis. These coordinated shifts demonstrate that low-RFI broilers harbor enhanced systemic amino acid utilization, lipid partitioning, and antioxidant defenses. Overall, this integrated approach uncovers gut-systemic metabolic interplay driving broiler FE that single-tissue studies fail to capture.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.